22 May 2013
Keywords: immune, response, ph, ii, data, corp, released
Article | 20 January 1997
The Immune Response Corp has released data from Phase II clinical trialswith its immune-based therapies for rheumatoid arthritis and psoriasis.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 January 1997
13 January 1997
27 January 1997
© 2013 thepharmaletter.com